Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Han, Eugene; Huh, Ji Hye; Lee, Eun Y.; Bae, Ji C.; Chun, Sung W.; Yu, Sung H.; Kwak, Soo H.; Park, Kyong S.; Lee, Byung-Wan

doi:10.1111/dom.14623

상세 보기

Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Han, Eugene;
Huh, Ji Hye;
Lee, Eun Y.;
Bae, Ji C.;
Chun, Sung W.;
외 4명

Citations

WEB OF SCIENCE

10

Citations

SCOPUS

10

키워드

dipeptidyl peptidase-4 inhibitor; evogliptin; magnetic resonance imaging-derived proton density fat fraction; non-alcoholic fatty liver disease; pioglitazone; type 2 diabetes; SITAGLIPTIN; MODEL; RISK

제목: Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

저자: Han, Eugene; Huh, Ji Hye; Lee, Eun Y.; Bae, Ji C.; Chun, Sung W.; Yu, Sung H.; Kwak, Soo H.; Park, Kyong S.; Lee, Byung-Wan

DOI: 10.1111/dom.14623

발행일: 2022-04

유형: Letter

저널명: Diabetes, Obesity and Metabolism

권: 24

호: 4

페이지: 752 ~ 756